AtriCure (ATRC) Cost of Revenue (2010 - 2026)

AtriCure (ATRC) has 17 years of Cost of Revenue data on file, last reported at $31.9 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $31.9 million, up 3.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $134.7 million (up 11.14% YoY), and the FY2025 annual result was $133.7 million, up 13.56% from the prior year.
• Cost of Revenue slipped to $31.9 million in Q1 2026 per ATRC's latest filing, from $35.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $35.2 million in Q4 2025 and troughed at $19.0 million in Q1 2022.
• A 5-year average of $27.5 million and a median of $27.6 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2026: Cost of Revenue increased 28.82% in 2022, then advanced 3.05% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $22.9 million in 2022, then increased by 16.64% to $26.7 million in 2023, then rose by 18.45% to $31.7 million in 2024, then rose by 11.07% to $35.2 million in 2025, then decreased by 9.17% to $31.9 million in 2026.
• Business Quant data shows ATRC's Cost of Revenue at $31.9 million in Q1 2026, $35.2 million in Q4 2025, and $32.9 million in Q3 2025.